AI Summary
Thinking
Thinking
We reviewed 12 live results for séquençage exome and narrowed them down to the 3 options that look most worth comparing first.
The options are Exome Sequencing, NEBNext Library Quant Kit for Illumina and MGZ.
Source: CeGaT GmbH
Description
CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days.
Best for
researchers, physicians, rare disease research and tumor profiling
Rate this product
Source: New England Biolabs
Description
NEBNext Library Quant Kit for Illumina de New England Biolabs est un kit de quantification précise des banques de séquençage nouvelle génération (NGS) par qPCR. Il permet d'estimer avec exactitude la concentration des fragments séquençables afin d'obtenir des densités d'amplifiats optimales pour le séquençage Illumina. Le kit comprend un tampon de dilution, un master mix optimisé, 4 étalons et du colorant ROX pour un protocole simple et hautement reproductible.
Best for
laboratoires de séquençage, chercheurs en génomique, quantification de banques de séquençage NGS pour Illumina and optimisation de la densité d'amplifiats de séquençage
Rate this product
Source: Unknown source
Description
MGZ is a medical genetics center offering comprehensive genetic testing services, including Clinical Exome and Whole Exome sequencing alongside phenotype-driven gene panels. Utilizing high-throughput next-generation sequencing (NGS), MGZ assists in diagnosing rare hereditary diseases and uncovering de-novo mutations through single and trio analyses. Diagnostic evaluations are performed on EDTA blood or purified DNA samples by medical specialists and scientists, delivering detailed clinical reports with high sequencing coverage and quality compliance.
Best for
Clinicians, Patients with suspected rare genetic conditions, Clinical genetic testing when standard gene panels are inconclusive and Diagnosing rare hereditary disorders via exome sequencing
Rate this product
| Compare | #1Exome Sequencing | #2NEBNext Library Quant Kit for Illumina | #3MGZ |
|---|---|---|---|
| Source | CeGaT GmbH | New England Biolabs | Unknown source |
| Description | CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days. | NEBNext Library Quant Kit for Illumina de New England Biolabs est un kit de quantification précise des banques de séquençage nouvelle génération (NGS) par qPCR. Il permet d'estimer avec exactitude la concentration des fragments séquençables afin d'obtenir des densités d'amplifiats optimales pour le séquençage Illumina. Le kit comprend un tampon de dilution, un master mix optimisé, 4 étalons et du colorant ROX pour un protocole simple et hautement reproductible. | MGZ is a medical genetics center offering comprehensive genetic testing services, including Clinical Exome and Whole Exome sequencing alongside phenotype-driven gene panels. Utilizing high-throughput next-generation sequencing (NGS), MGZ assists in diagnosing rare hereditary diseases and uncovering de-novo mutations through single and trio analyses. Diagnostic evaluations are performed on EDTA blood or purified DNA samples by medical specialists and scientists, delivering detailed clinical reports with high sequencing coverage and quality compliance. |
| Best for | researchers, physicians, rare disease research and tumor profiling | laboratoires de séquençage, chercheurs en génomique, quantification de banques de séquençage NGS pour Illumina and optimisation de la densité d'amplifiats de séquençage | Clinicians, Patients with suspected rare genetic conditions, Clinical genetic testing when standard gene panels are inconclusive and Diagnosing rare hereditary disorders via exome sequencing |
| Action | CeGaT GmbH | New England Biolabs | |
| Rate this product |
"Exome Sequencing from CeGaT GmbH."
Note: TopFind AI compiles product and service information for general comparison purposes only.